MLAB
NASDAQ · Life Sciences Tools & Services
Mesa Laboratories Inc
$135.20
-4.01 (-2.88%)
Financial Highlights (FY 2026)
Revenue
262.63M
Net Income
7.08M
Gross Margin
63.5%
Profit Margin
2.7%
Rev Growth
+4.4%
D/E Ratio
0.81
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 63.5% | 63.5% | 47.0% | 47.0% |
| Operating Margin | 7.4% | 6.7% | 10.0% | 10.8% |
| Profit Margin | 2.7% | 2.6% | 7.4% | 9.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 262.63M | 251.63M | 397.89M | 376.18M |
| Gross Profit | 166.85M | 159.86M | 187.01M | 176.81M |
| Operating Income | 19.51M | 16.83M | 39.90M | 40.62M |
| Net Income | 7.08M | 6.10M | 29.46M | 36.94M |
| Gross Margin | 63.5% | 63.5% | 47.0% | 47.0% |
| Operating Margin | 7.4% | 6.7% | 10.0% | 10.8% |
| Profit Margin | 2.7% | 2.6% | 7.4% | 9.8% |
| Rev Growth | +4.4% | +4.4% | +8.2% | -1.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 156.95M | 156.95M | 71.22M | 83.37M |
| Total Equity | 192.98M | 192.98M | 387.20M | 405.59M |
| D/E Ratio | 0.81 | 0.81 | 0.18 | 0.21 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 35.55M | 32.36M | 61.24M | 58.33M |
| Free Cash Flow | — | — | 38.36M | 33.12M |